Friday, January 6, 2017

Bovie Medical Corporation (BVX) CEO to Present at Biotech Showcase 2017

Earlier this week, Bovie Medical Corporation (NYSE MKT: BVX), a leading developer of medical devices and supplies, announced its plans to participate in the 9th Annual Biotech Showcase Conference, which is set to take place at the Hilton San Francisco Union Square from January 9-11. Robert L. Gershon, the company’s chief executive officer, is scheduled to present to investors at 11:00 am PST on Tuesday, January 10. Planned talking points include Bovie Medical’s recent activities, as well as the company’s innovative J-Plasma® surgical instrument. Additionally, Gershon is expected to present at Medtech Showcase at the Parc 55 San Francisco Hotel in Union Square on Wednesday, January 11 at 10:30 am PST.

To learn more about Biotech Showcase 2017, visit

Bovie Medical – named for the inventor of modern electrosurgery, Dr. William T. Bovie – leverages a portfolio of proprietary technology and expertise spanning the design, development and manufacture of electrosurgical equipment to create advanced energy devices that it markets around the globe. The company maintains a number of well-respected brands, including Bovie®, Aaron®, IDS™ and ICON™, in addition to marketing its products through private labels.

J-Plasma® is Bovie Medical’s leading product. A plasma-based surgical product for cutting and coagulation, J-Plasma® combines the unique properties of cold helium plasma with RF energy to give surgeons greater precision, minimal invasiveness and an absence of potentially dangerous conductive currents through patients during surgery. To date, the product has been used successfully in a wide array of surgical procedures, such as capsular scoring, wound debridement and scar revision. J-Plasma® is still in the early stages of commercialization, according to the company’s website, but Bovie Medical believes that it has the potential to become a “transformational product for surgeons.”

In August 2016, the market potential of J-Plasma® was reaffirmed when a portion of the J-Plasma® platform was recognized as an “Innovation of the Year” by The Society of Laparoendoscopic Surgeons for the third consecutive year. The Precise 360™ hand piece, which received this year’s distinction, features an angled and rotating tip that allows surgeons to access structures that are difficult to reach with a straight laparoscopic device. In 2014, the J-Plasma® product line received the same distinction, and, in 2015, the title was given to the Bovie Ultimate™ Operating Room Generator, which combines J-Plasma® technology with the highest wattage monopolar and bipolar electrosurgical generator.

For more information, visit

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at

The Quality Stocks Daily Blog

The Quality Stocks Daily Videos

The Quality Stocks “Ones to Watch”

Please see disclaimer on the QualityStocks website:

No comments: